Patient Assistance Program Allows Company to Increase Drug Prices While Passing Costs onto Insurance Companies and Consumers WASHINGTON, DC — In a letter sent today to the CEO of pharmaceutical company Mylan, Senators Jack Reed and Sheldon Whitehouse, along with 18 of their Senate colleagues, expressed their serious concerns about the company’s significant price hikes for the life-saving EpiPen Auto-Injector. The Senators raised questions about Mylan’s decision to expand its patient assistance program, which allows the company to sharply increase prices while passing the cost of these increases onto insurance companies and ultimately to consumers, and to introduce an authorized…
Read More »